
O-304
CAS No. 1261289-04-6
O-304( O304 )
Catalog No. M11082 CAS No. 1261289-04-6
O-304 is a small molecule AMPK activator and PCSK9 modulator, reduces extracellular and secreted PCSK9 levels in human liver cells and reduces PCSK9 plasma levels and total cholesterol levels in obese rats.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 79 | In Stock |
![]() ![]() |
5MG | 132 | In Stock |
![]() ![]() |
10MG | 205 | In Stock |
![]() ![]() |
25MG | 410 | In Stock |
![]() ![]() |
50MG | 605 | In Stock |
![]() ![]() |
100MG | 860 | In Stock |
![]() ![]() |
500MG | 1728 | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameO-304
-
NoteResearch use only, not for human use.
-
Brief DescriptionO-304 is a small molecule AMPK activator and PCSK9 modulator, reduces extracellular and secreted PCSK9 levels in human liver cells and reduces PCSK9 plasma levels and total cholesterol levels in obese rats.
-
DescriptionO-304 is a small molecule AMPK activator and PCSK9 modulator, reduces extracellular and secreted PCSK9 levels in human liver cells and reduces PCSK9 plasma levels and total cholesterol levels in obese rats.Diabetes Phase 2 Clinical.
-
In Vitro——
-
In Vivo——
-
SynonymsO304
-
PathwayOthers
-
TargetPCSK9
-
RecptorPCSK9
-
Research AreaMetabolic Disease
-
IndicationDiabetes
Chemical Information
-
CAS Number1261289-04-6
-
Formula Weight380.243
-
Molecular FormulaC16H11Cl2N3O2S
-
Purity>98% (HPLC)
-
SolubilityDMSO : 30 mg/mL 78.90 mM
-
SMILESC1=CC(=CC=C1CN2C(=O)N=C(S2)NC(=O)C3=CC=C(C=C3)Cl)Cl
-
Chemical Name4-chloro-N-(2-(4-chlorobenzyl)-3-oxo-2,3-dihydro-1,2,4-thiadiazol-5-yl)benzamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Daniel Pettersen, et al. Small molecule modulators of PCSK9-a literature and patent overview. Bioorg Med Chem Lett. 2018 Feb 26. pii: S0960-894X(18)30151-3.
molnova catalog



related products
-
Evolocumab
Evolocumab is a human IgG2 monoclonal antibody that binds to human PCSK9 Proprotein Convertase Subtilisin Kexin Type 9).
-
PF-06815345
PF-06815345 (PF 6815345) is a potent prodrug PCSK9 modulator that inhibits PCSK9 secretion in vitro translation assay.
-
Alirocumab
Alirocumab is a human monoclonal antibody that inhibits PCSK9. It is produced by recombinant DNA technology in Chinese hamster ovary cell suspension culture.